Brian P. Zambrowicz is EVP & Chief Scientific Officer at LEXICON PHARMACEUTICALS, INC./DE (LXRX). They have made 1 open-market trade across 1 company since 2007, most recently 2014-02-28.
CIK 0001226231
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LEXG | SELL | 2007-02-01 | 2007-02-02 | $3.89 | $203K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.